Vishal Duggal

Company: Genentech

Job title: Associate Medical Director

Seminars:

Deciphering the Precise Role of Complement Activation in IgA Nephropathy to Develop Therapeutic Inhibitors 11:45 am

Discussing the role of the complement cascade in the pathogenesis of IgA nephropathy Review results of the Phase II trial of RO7434656, an antisense oligonucleotide targeting complement Providing an overview of the Phase III IMAgINATION trial of RO7434656 in patients with IgA nephropathyRead more

day: Pre-Conference Seminar Day

Panel Discussion | Novel Targets in Development for IgA Nephropathy: Where are the Current Late Phase Trials Heading? 11:00 am

From complement to APRIL to ETA: what targets are currently in development and looking most promising? Exploring new treatment possibilities with combinational targeting Exploring the current thinking on IgA pathogenesis to direct priorities for future target developmentRead more

day: Pre-Conference Seminar Day